Health & Safety Industry Today
What's driving the Cancer Drugs Market growth? AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd
The global oncology/cancer drugs market was valued at $97,401 million in 2017, and is estimated to reach at $176,509 million by 2025, registering a CAGR of 7.6% from 2018 to 2025.
Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option to treat various cancer types, especially blood cancer (leukemia). Rise in incidence of various cancer conditions, increase in popularity of advance therapies (biological and targeted drug therapies), and surge in geriatric population worldwide are the key factors driving the growth of the global oncology/cancer drugs market. Furthermore, rise in cancer awareness and availability of cancer drugs are expected to boost the market growth.
Request for a sample copy of this report @ https://www.bigmarketresearch.com/request-sample/22695/?utm_source=SBL
However, high cost involved in new drug development coupled with threat of failure & adverse effects associated with cancer drugs therapies is expected to restrain the growth of the market. Conversely, high potential of emerging economies and increase in number of pipeline products are expected to provide new opportunities for market players in future.
The global oncology/cancer drugs market is segmented based on drug class type, indication, and region. Depending on drug class type, the market is divided into chemotherapy, targeted therapy, immunotherapy (biologic therapy), and hormonal therapy. By indication, it is categorized into lung cancer, stomach cancer, colorectal cancer, breast cancer, prostate cancer, liver cancer, esophagus cancer, cervical cancer, kidney cancer, bladder cancer, and other cancers.
Region wise, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Enquiry Before Buying @ https://www.bigmarketresearch.com/purchase-enquiry/22695/?utm_source=SBL
The major players profiled in this study include: AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Bristol-Myers Squibb Company, Celgene Corporation, F. Hoffmann-La Roche Ltd., Johnson & Johnson (Janssen Global Services, LLC,), Merck & Co., Inc., Novartis AG and Pfizer Inc.
LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request) : Sanofi, Amgen Inc., Bayer AG and Exelixis, Inc.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2017 to 2025, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all the geographical regions is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.
Oncology/Cancer Drugs Market Key Segments:
By Drug Class Type: Chemotherapy, Targeted Therapy, Immunotherapy (Biologic Therapy), Hormonal Therapy
By Indication: Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Esophagus Cancer, Cervical Cancer, Kidney Cancer, Bladder Cancer and Other Cancers
By Country:
North America: U.S., Canada, Mexico
Europe: UK, Germany, France, Spain, Italy, Rest of Europe
Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
LAMEA: Chile, Israel, South Africa, Rest of LAMEA
Access Full Summery @ https://www.bigmarketresearch.com/oncology-cancer-drugs-market/?utm_source=SBL
Table of content:
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: ONCOLOGY/CANCER DRUGS MARKET, BY FILTER TYPE
CHAPTER 5: ONCOLOGY/CANCER DRUGS MARKET, BY APPLICATION
CHAPTER 6: ONCOLOGY/CANCER DRUGS MARKET, BY DISTRIBUTION CHANNEL
CHAPTER 7: ONCOLOGY/CANCER DRUGS MARKET, BY REGION
CHAPTER 8: COMPANY PROFILES
Similar Publisher Related report:
Global Oncology/Cancer Drugs Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
About Us:
Big Market Research has a range of research reports from various publishers across the world. Our database of reports of various market categories and sub-categories would help to find the exact report you may be looking for.
We are instrumental in providing quantitative and qualitative insights on your area of interest by bringing reports from various publishers at one place to save your time and money. A lot of organizations across the world are gaining profits and great benefits from information gained through reports sourced by us.
Contact Us:
Mr. Abhishek Paliwal
5933 NE Win Sivers Drive, #205, Portland,
OR 97220 United States
call answer Direct:+1-971-202-1575
call answer Toll Free:+1-800-910-6452
email help@bigmarketresearch.com
Share on Social Media
Other Industry News
Ready to start publishing
Sign Up today!
